Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma
Br J Surg
.
2022 Aug 16;109(9):e106.
doi: 10.1093/bjs/znac160.
Authors
Arnaldo N S Silva
1
2
3
,
Yuichi Saito
4
5
,
Takaki Yoshikawa
6
,
Takashi Oshima
7
,
Jeremy D Hayden
8
,
Jan Oosting
9
,
Sophie Earle
1
,
Lindsay C Hewitt
1
5
,
Hayley L Slaney
1
,
Alex Wright
1
,
Imran Inam
1
,
Ruth E Langley
10
,
William H Allum
11
,
Matthew G Nankivell
10
,
Gordon Hutchins
1
,
David Cunningham
12
,
Heike I Grabsch
1
5
Affiliations
1
Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
2
Department of Surgery, University of Cambridge, Cambridge University Hospitals, Addenbrookes, Cambridge, UK.
3
Cancer Research UK, Cambridge Institute, Cambridge, UK.
4
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
5
Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands.
6
Department of Gastric Surgery, National Cancer Centre Hospital, Tokyo, Japan.
7
Department of Gastrointestinal Surgery, Kanagawa Cancer Centre Hospital, Yokohama, Japan.
8
Department of Upper Gastrointestinal Surgery, Institute of Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
9
Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
10
MRC Clinical Trials Unit, University College London, London, UK.
11
Department of Surgery, Royal Marsden Hospital, London, UK.
12
Department of Medicine, Royal Marsden NHS Trust, London and Sutton, UK.
PMID:
35554502
PMCID:
PMC10364771
DOI:
10.1093/bjs/znac160
No abstract available
Publication types
Comment
MeSH terms
Adenocarcinoma* / genetics
Adenocarcinoma* / pathology
Gene Dosage
Humans
Immunosuppression Therapy
Prognosis
Stomach Neoplasms* / genetics
Stomach Neoplasms* / pathology